Building the Case for HER-2 Inhibitors in NSCLC

Building the Case for HER-2 Inhibitors in NSCLC

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Corey Langer, MD

Date of Release

May 14th, 2025